Alpha Mark Advisors, LLC Novartis Ag Transaction History
Alpha Mark Advisors, LLC
- $231 Million
- Q4 2024
A detailed history of Alpha Mark Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Alpha Mark Advisors, LLC holds 700 shares of NVS stock, worth $74,893. This represents 0.03% of its overall portfolio holdings.
Number of Shares
700
Previous 700
-0.0%
Holding current value
$74,893
Previous $81,000
16.05%
% of portfolio
0.03%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding NVS
# of Institutions
1,446Shares Held
130MCall Options Held
1.12MPut Options Held
1.61M-
Dodge & Cox San Francisco, CA12.2MShares$1.31 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.18 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$876 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.98MShares$747 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.58MShares$597 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $230B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...